Document Detail

Effect of ultra-rapid opiate detoxification on withdrawal syndrome.
MedLine Citation:
PMID:  20924880     Owner:  NLM     Status:  In-Process    
The aim of study was determine the effect of ultra-rapid opiate detoxification (UROD) on the presence or absence of withdrawal syndrome in a group of patients with opiate dependency. In this study, withdrawal syndrome of 173 patients with opiate addiction was evaluated before and after UROD using the Objective Opioid Withdrawal Scale. Hence, each patient was observed for 5 minutes before UROD and at different hours afterward to observe any withdrawal sign. The most prevalent withdrawal sign before UROD was anxiety. Restlessness was the most prevalent finding at 1, 3, and 6 hours. After 12 hours, yawning was reported as the most prevalent finding in 39 participants. Anxiety was reported as the most prevalent finding in 61 participants after 24 hours. Patients with opioid dependency who underwent UROD showed the highest rate of withdrawal symptoms at one hour after anesthesia. Most of these symptoms subsided after 24 hours. UROD can be applied for detoxification of patients with opioid dependency with safety.
Farhad Safari; Kamran Mottaghi; Saeed Malek; Alireza Salimi
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of addictive diseases     Volume:  29     ISSN:  1545-0848     ISO Abbreviation:  J Addict Dis     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107051     Medline TA:  J Addict Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  449-54     Citation Subset:  IM    
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Advanced urine toxicology testing.
Next Document:  Erectile dysfunction in opioid users: lack of association with serum testosterone.